Intravitreal silicone oil droplets following pegaptanib injection.
Kocabora
Mehmet Selim
MS
Ozbilen
Kemal Turgay
KT
Serefoglu
Kubra
K
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D052157:Aptamers, Nucleotide / Q000008:administration & dosage*; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D005128:Eye Diseases / Q000000981:diagnostic imaging / Q000209:etiology*; D005129:Eye Foreign Bodies / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D007267:Injections; D013058:Mass Spectrometry; D012825:Silicon / Q000737:chemistry; D012827:Silicone Oils; D014463:Ultrasonography; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014822:Vitreous Body / Q000000981:diagnostic imaging / Q000473:pathology*
D020533:Angiogenesis Inhibitors; D052157:Aptamers, Nucleotide; D012827:Silicone Oils; D042461:Vascular Endothelial Growth Factor A; C495058:pegaptanib; D012825:Silicon